Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity.

Author: ChienHuan-Chieh, FennerKatherine S, GiacominiKathleen M, GuptaAnshul, PrasadBhagwat, StahlSimone H, SteculaAdrian, UnadkatJashvant D, WangLi, YeeSook Wah, ZouLing

Paper Details 
Original Abstract of the Article :
Species differences in renal drug transporters continue to plague drug development with animal models failing to adequately predict renal drug toxicity. For example, adefovir, a renally excreted antiviral drug, failed clinical studies for human immunodeficiency virus due to pronounced nephrotoxicity...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987998/

データ提供:米国国立医学図書館(NLM)

Unveiling Species Differences in Organic Anion Transporter 1: Implications for Renal Drug Toxicity

Species differences in renal drug transporters often pose significant challenges in drug development, making it difficult to accurately predict drug toxicity in humans based on animal models. This study investigates the molecular mechanisms underlying species differences in the organic anion transporter 1 (OAT1), a critical transporter for renal drug excretion. The researchers identified a key amino acid residue responsible for differences in the transport kinetics of acyclic nucleoside phosphonates (ANPs), a class of antiviral drugs, in different species. Their findings suggest that these species differences could explain discrepancies in renal drug toxicity observed in humans and animal models.

OAT1: A Molecular Key to Understanding Renal Drug Toxicity

This research provides valuable insights into the molecular mechanisms governing renal drug transport, helping to explain the differences in drug toxicity observed across species. The study's findings could lead to improved drug development strategies and more accurate predictions of drug toxicity in humans.

From Animal Models to Human Health: Bridging the Gap in Drug Development

The study emphasizes the importance of understanding species differences in drug transport mechanisms to develop more effective and safer drugs for human use. By bridging the gap between animal models and human responses, researchers can pave the way for more personalized and effective drug therapies.

Dr. Camel's Conclusion

Just as a camel adapts to survive in different desert ecosystems, researchers are exploring the diverse ways in which drugs interact with different species. This study highlights the importance of understanding species differences in renal drug transporters, a crucial step in developing safe and effective medications for human use. By navigating the complexities of drug transport mechanisms, researchers can pave the way for more precise and personalized drug therapies.

Date :
  1. Date Completed 2019-02-22
  2. Date Revised 2019-07-01
Further Info :

Pubmed ID

29720497

DOI: Digital Object Identifier

PMC5987998

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.